Hair & Scalp

The virtual Global Hair Loss Summit, on December 17 and 18, presents the latest news about surgical hair restoration through panels, faculty talks, and a wide range of presentations.

Alopecia areata can have devastating effects on patients, but a greater understanding of its pathophysiology has led to the development of new treatment options.

At the 2022 Fall Clinical Dermatology Conference, 3 expert clinicians share their strategies for diagnosing and managing alopecia areata.

At the 2022 Fall Clinical Dermatology Conference,a presenter looks at the best treatments for hair loss and nail fungus.

Taking a deep dive into alopecia areata allows for a better understanding of the cells that are responsible for disease development.

While PRP for hair loss can work very well, in most cases patients are not even getting real PRP. Watch this video to find out the real story on PRP, and where you can go to get the proper treatment.

Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.

Edgewell Personal Care Company issued a voluntary national recall of 3 collections of Banana Boat Hair & Scalp Sunscreen due to the presence of benzene.

The FUE Europe Hair Transplant Society Conference, taking place September 15-17, 2022 in Athens, Greece, has been sanctioned by the American Hair Loss Association.

Perimenopausal, menopausal, and postmenopausal women experienced a progressive improvement in hair growth, shedding, quality of life, and menopausal symptoms after 12 months with an active nutraceutical supplement.

Theodore Rosen, MD, presents the best therapies for central centrifugal cicatricial alopecia and fontal fibrosing alopecia.

In this week’s Pointers with Dr Portela, the 208SkinDoc talks the newest approval of baricitinib (Olumiant; Eli Lilly and Company) for the treatment of alopecia areata.

At the SDPA 2022 Annual Summer Dermatology Conference, a session on both common and rare dermatological disorders.

First clinical results for the treatment of central centrifugal cicatricial alopecia in Black women introduce more inclusive solutions.

This marks the first FDA approval of a systemic treatment for alopecia areata.

In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, tackles the issues of hair loss after pregnancy, the role of pH in hair care, hair strengthening conditioner, and more.

Veronica Richardson, MSN, ANP-BC, DCNP, discussed how she diagnoses hair loss subtypes in her session at the 3rd Annual Society of Dermatology Nurse Practitioners Symposium.

A comprehensive review explored new uses of this popular technology in aesthetic and medical dermatology.

Arcutis Biotherapeutics announced news of its topical roflumilast foam’s trial on safety and efficacy of treatment in scalp and body psoriasis.

A multicenter investigation provides information on the prevalence and incidence of alopecia areata in children.

The skincare manufacturer and distributer announced that it has received patents for hair growth and melasma.

A dermatologist needs to know how to treat every patient, regardless of skin or hair type. These pointers will help guide conversations with patients for the best possible hair care.

A poster presentation from Follica at the 2022 Winter Clinical Dermatology Conference and 2022 Maui Derm for Dermatology meeting found that 56% of survey responders did not seek treatment for their hair loss, and that 19% of respondents who attempted treatment quit because of lack of efficacy or cost.

FUE is a type of hair transplant that requires physicians to change tools to accommodate different hair and scalp types. Now, a recent study highlights a single device aiming to treat all types of hair situations.

A patients’ race and cultural background may be a factor in how the hair ages, according to a study in the Journal of Clinical and Aesthetic Dermatology.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explores scalp flaking causes and treatments.

Seborrheic dermatitis will affect roughly half of all infants, making knowing how to treat and manage it key.

A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.

In this exclusive video interview, James Q Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the headlines around the treatments.

The potential of JAK inhibitors and other emerging medications could answer demand for more treatment options for these challenging skin conditions. Read down below.